$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000094480915000008 Filed on May 11, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$30.08M	$22.27M
YoY Change	35.06%	-29.01%
Cost Of Revenue	$10.32M	$12.39M
YoY Change	-16.71%	5.39%
Gross Profit	$19.76M	$9.883M
YoY Change	99.98%	-74.09%
Gross Profit Margin	65.7%	44.37%
Selling, General & Admin	$17.45M	$13.81M
YoY Change	26.31%	11.17%
% of Gross Profit	88.27%	139.76%
Research & Development	$25.50M	$20.99M
YoY Change	21.48%	111.85%
% of Gross Profit	129.04%	212.43%
Depreciation & Amortization	$3.525M	$3.564M
YoY Change	-1.09%	3.94%
% of Gross Profit	17.84%	36.06%
Operating Expenses	$87.00M	$52.55M
YoY Change	65.55%	37.75%
Operating Profit	-$56.91M	-$30.28M
YoY Change	87.98%	347.02%
Interest Expense	-$52.30M	-$14.00M
YoY Change	273.57%	-46.97%
% of Operating Profit
Other Income/Expense, Net	-$53.85M	-$12.14M
YoY Change	343.45%	-49.52%
Pretax Income	-$110.8M	-$42.42M
YoY Change	161.11%	37.6%
Income Tax	$5.509M	$614.0K
% Of Pretax Income
Net Earnings	-$118.0M	-$44.55M
YoY Change	164.95%	30.21%
Net Earnings / Revenue	-392.36%	-200.01%
Basic Earnings Per Share	-$0.26	-$0.11
Diluted Earnings Per Share	-$0.26	-$0.11
COMMON SHARES
Basic Shares Outstanding	451.6M shares	412.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$348.2M	$156.4M
YoY Change	122.63%	-13.88%
Cash & Equivalents	$348.2M	$156.4M
Short-Term Investments
Other Short-Term Assets	$3.384M	$5.655M
YoY Change	-40.16%	-52.48%
Inventory	$18.32M	$18.87M
Prepaid Expenses
Receivables	$19.06M	$19.66M
Other Receivables	$2.700M	$1.800M
Total Short-Term Assets	$394.0M	$205.3M
YoY Change	91.95%	-13.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$15.12M	$16.88M
YoY Change	-10.43%	0.78%
Goodwill	$223.2M	$226.1M
YoY Change	-1.26%	173.32%
Intangibles
YoY Change
Long-Term Investments	$12.70M	$28.90M
YoY Change	-56.06%	1.4%
Other Assets	$5.073M	$6.520M
YoY Change	-22.19%	127.73%
Total Long-Term Assets	$1.118B	$1.150B
YoY Change	-2.8%	176.38%
TOTAL ASSETS
Total Short-Term Assets	$394.0M	$205.3M
Total Long-Term Assets	$1.118B	$1.150B
Total Assets	$1.512B	$1.356B
YoY Change	11.55%	107.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.47M	$14.70M
YoY Change	-28.74%	30.2%
Accrued Expenses	$158.8M	$58.77M
YoY Change	170.13%	120.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$13.60M	$11.03M
YoY Change	23.3%	-45.56%
Total Short-Term Liabilities	$182.8M	$84.50M
YoY Change	116.38%	45.13%
LONG-TERM LIABILITIES
Long-Term Debt	$2.185M	$3.101M
YoY Change	-29.54%	-98.42%
Other Long-Term Liabilities	$410.2M	$215.1M
YoY Change	90.65%	170.58%
Total Long-Term Liabilities	$516.8M	$439.9M
YoY Change	17.48%	59.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$182.8M	$84.50M
Total Long-Term Liabilities	$516.8M	$439.9M
Total Liabilities	$699.7M	$524.4M
YoY Change	33.41%	56.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$792.0M	-$547.7M
YoY Change	44.59%	29.49%
Common Stock	$4.593M	$4.154M
YoY Change	10.57%	22.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.051M	$7.300M
YoY Change	-44.51%	-2.11%
Treasury Stock Shares	1.245M shares	2.245M shares
Shareholders Equity	$819.9M	$835.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.512B	$1.356B
YoY Change	11.55%	107.31%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$118.0M	-$44.55M
YoY Change	164.95%	30.21%
Depreciation, Depletion And Amortization	$3.525M	$3.564M
YoY Change	-1.09%	3.94%
Cash From Operating Activities	$238.8M	-$22.61M
YoY Change	-1156.09%	53.35%
INVESTING ACTIVITIES
Capital Expenditures	-$400.0K	-$900.0K
YoY Change	-55.56%	12.5%
Acquisitions	$0.00	$200.0K
YoY Change	-100.0%	-356.41%
Other Investing Activities	$0.00	-$1.297M
YoY Change	-100.0%	-48.69%
Cash From Investing Activities	-$363.0K	-$264.0K
YoY Change	37.5%	-59.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$13.81M	-$6.531M
YoY Change	-311.48%	-103.85%
NET CHANGE
Cash From Operating Activities	$238.8M	-$22.61M
Cash From Investing Activities	-$363.0K	-$264.0K
Cash From Financing Activities	$13.81M	-$6.531M
Net Change In Cash	$252.2M	-$29.41M
YoY Change	-957.79%	-119.06%
FREE CASH FLOW
Cash From Operating Activities	$238.8M	-$22.61M
Capital Expenditures	-$400.0K	-$900.0K
Free Cash Flow	$239.2M	-$21.71M
YoY Change	-1201.71%	55.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	458424686	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	Opko Health, Inc.
CY2014Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	8643000	USD
CY2015Q1	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	9620000	USD
CY2014Q4	opk	Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet	-3232000	USD
CY2015Q1	opk	Availablefor Sale Securities Accumulated Gross Realized Gain Loss Net AvailableforSaleSecuritiesAccumulatedGrossRealizedGainLossNet	-6856000	USD
CY2015Q1	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Discount Rates Increase One Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfDiscountRatesIncreaseOnePercent	1700000	USD
CY2015Q1	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	2000000	USD
CY2014Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1100000000	USD
CY2015Q1	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	1100000000	USD
CY2014Q1	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	0	USD
CY2015Q1	opk	Collaborative Arrangement Grant Repayment CollaborativeArrangementGrantRepayment	25889000	USD
CY2014Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	657000	USD
CY2015Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	14238000	USD
CY2014Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	12	institution
CY2015Q1	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	8	institution
CY2015Q1	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	7219000	USD
CY2015Q1	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	939000	USD
CY2014Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-43035000	USD
CY2015Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-116276000	USD
CY2014Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	3486000	USD
CY2015Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2565000	USD
CY2014Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	40000	USD
CY2015Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	8000	USD
CY2012Q3	opk	Numberof Medicare Claims Includedin Post Payment Review Audit NumberofMedicareClaimsIncludedinPostPaymentReviewAudit	183	claim
CY2015Q1	opk	Percentage Of Increase Decrease In Discount Rate PercentageOfIncreaseDecreaseInDiscountRate	0.01
CY2015Q1	opk	Percentage Of Increase Decrease In Future Sales PercentageOfIncreaseDecreaseInFutureSales	0.10
CY2014Q1	opk	Revenue From Receipt Of Equity RevenueFromReceiptOfEquity	60000	USD
CY2015Q1	opk	Revenue From Receipt Of Equity RevenueFromReceiptOfEquity	60000	USD
CY2014Q1	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	476000	USD
CY2015Q1	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	12529000	USD
CY2015Q1	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	1206609	shares
CY2015Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	21735636	shares
CY2015Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	20529027	shares
CY2015Q1	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	9723000	USD
CY2014Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	2417000	USD
CY2015Q1	opk	Taxes Recoverable Current TaxesRecoverableCurrent	1968000	USD
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	669000	USD
CY2015Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	733000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8744000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	10472000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	21875000	USD
CY2015Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	20755000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19969000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19064000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	4127000	USD
CY2015Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	6495000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	77000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3008000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60912000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	158763000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1860000	USD
CY2015Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1624000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12392000	USD
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-17503000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1529096000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1628818000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1906000	USD
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1691000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	177000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	751000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2744000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2665000	USD
CY2014Q4	us-gaap	Assets Assets	1267664000	USD
CY2015Q1	us-gaap	Assets Assets	1512249000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	142869000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	394025000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	12072000	USD
CY2015Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	14222000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	509000	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1082000	USD
CY2014Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2610000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	5175000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4573000	USD
CY2015Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6620000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	12904000	USD
CY2015Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	12904000	USD
CY2015Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	4499000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	71600000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	76500000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	27352000	USD
CY2015Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	52838000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	185798000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156396000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	96907000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348192000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-29402000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	251285000	USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	433421677	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	459314572	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	4334000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	4593000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-46570000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-122223000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-540000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-925000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-47110000	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-123148000	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	131454000	USD
CY2015Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	106673000	USD
CY2014Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12391000	USD
CY2015Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10320000	USD
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	6700000	USD
CY2015Q1	us-gaap	Deferred Revenue DeferredRevenue	288800000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4185000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	74789000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2526000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	214017000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	167153000	USD
CY2015Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	166922000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3564000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3525000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	4000	USD
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-957000	USD
CY2015Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	53700000	USD
CY2015Q1	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	112100000	USD
CY2015Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	373400000	USD
CY2015Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	51000000	USD
CY2015Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-37800000	USD
CY2015Q1	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	19050000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	33931000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	35928000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	62649000	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59432000	USD
CY2014Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	976000	USD
CY2015Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-473000	USD
CY2014Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-10373000	USD
CY2015Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-49788000	USD
CY2014Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2056000	USD
CY2015Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1761000	USD
CY2014Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1273000	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	216000	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-321000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	224292000	USD
CY2015Q1	us-gaap	Goodwill Goodwill	223219000	USD
CY2015Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2015Q1	us-gaap	Goodwill Other Changes GoodwillOtherChanges	-1073000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-42421000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-110767000	USD
CY2014Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2056000	USD
CY2015Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1761000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	614000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5509000	USD
CY2014Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	377000	USD
CY2015Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	227000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1479000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2107000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	557000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	103000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1526000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4413000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-46000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	282238000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1676000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-944000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2610000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1429000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	509000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1287000	USD
CY2014Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	793152000	USD
CY2015Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	793000000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	2420000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	1568000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12116000	USD
CY2015Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	14349000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	16604000	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	18324000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4116000	USD
CY2015Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	3638000	USD
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	639000	USD
CY2015Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	554000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1011000	USD
CY2015Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	891000	USD
CY2014Q1	us-gaap	Inventory Write Down InventoryWriteDown	337000	USD
CY2015Q1	us-gaap	Inventory Write Down InventoryWriteDown	220000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	431923000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	699676000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1267664000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1512249000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	83111000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	182838000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	348812000	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	516838000	USD
CY2014Q4	us-gaap	Line Of Credit LineOfCredit	7658000	USD
CY2015Q1	us-gaap	Line Of Credit LineOfCredit	7893000	USD
CY2015Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	13261000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	13455000	USD
CY2015Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	13603000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2434000	USD
CY2015Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2185000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	22453000	USD
CY2015Q1	us-gaap	Long Term Investments LongTermInvestments	22380000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	-6403000	USD
CY2015Q1	us-gaap	Minority Interest MinorityInterest	-7329000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6531000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13812000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-264000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-363000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22611000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238793000	USD
CY2014Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-540000	USD
CY2015Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-925000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44551000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-117112000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12144000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-53853000	USD
CY2015Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	52551000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	86998000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-30277000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-56914000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14668000	USD
CY2015Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10389000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4212000	USD
CY2015Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3384000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5838000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5073000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-5111000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1801000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3852000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5111000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	553000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	335000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1259000	USD
CY2014Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	1030000	USD
CY2015Q1	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	3368000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	217358000	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	410165000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1675000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1508000	USD
CY2014Q1	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	6264000	USD
CY2015Q1	us-gaap	Other Significant Noncash Transaction Value Of Consideration Received1 OtherSignificantNoncashTransactionValueOfConsiderationReceived1	0	USD
CY2014Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1777000	USD
CY2015Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1056000	USD
CY2014Q1	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	6435000	USD
CY2015Q1	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	0	USD
CY2014Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1297000	USD
CY2015Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2014Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	200000	USD
CY2015Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2014Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	500000	USD
CY2015Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2014Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	861000	USD
CY2015Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	363000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9389000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8445000	USD
CY2014Q4	us-gaap	Prepaid Insurance PrepaidInsurance	968000	USD
CY2015Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1041000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1639000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	12712000	USD
CY2014Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4250000	USD
CY2015Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5158000	USD
CY2014Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2015Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	791000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	-45091000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-118037000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16411000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15120000	USD
CY2014Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-74000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	174000	USD
CY2015Q1	us-gaap	Purchase Obligation PurchaseObligation	13900000	USD
CY2015Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	USD
CY2014Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5985000	USD
CY2015Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	4849000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20994000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25503000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-674843000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-791955000	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19828000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	15486000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	22274000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	30084000	USD
CY2014Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1970000	USD
CY2015Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2069000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13812000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17446000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3579000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7382000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	842144000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	819902000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	835741000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	812573000	USD
CY2014Q4	us-gaap	Supplies Supplies	1123000	USD
CY2015Q1	us-gaap	Supplies Supplies	1319000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1245367	shares
CY2015Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1245367	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4051000	USD
CY2015Q1	us-gaap	Treasury Stock Value TreasuryStockValue	4051000	USD
CY2015Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	2300000	USD
CY2014Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	7600000	USD
CY2015Q1	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets VariableInterestEntityConsolidatedCarryingAmountAssets	7100000	USD
CY2014Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	12100000	USD
CY2015Q1	us-gaap	Variable Interest Entity Consolidated Carrying Amount Liabilities VariableInterestEntityConsolidatedCarryingAmountLiabilities	12100000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	412909809	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	446480884	shares
CY2015Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassification and correction of immaterial error. </font><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2014, we reported payments for contingent consideration and some deferred payments as cash outflows from operating activities. Amounts paid pertaining to the initial purchase accounting contingent liabilities should have been classified as cash outflows from financing activities. Amounts paid in excess of the initial purchase accounting contingent liabilities have been classified as cash outflows from operating activities. We have corrected the amounts previously reported in our Form 10-Q for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31, 2014</font><font style="font-family:inherit;font-size:10pt;"> in conjunction with the filing of this Form 10-Q by reducing cash outflows from operating activities and increasing cash outflows from financing activities by </font><font style="font-family:inherit;font-size:10pt;">$6.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the first quarter of 2014. </font></div></div>
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000944809-15-000008-index-headers.html	Edgar Link	pending
0000944809-15-000008-index.html	Edgar Link	pending
0000944809-15-000008.txt	Edgar Link	pending
0000944809-15-000008-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
opk-20150331.xml	Edgar Link	completed
opk-20150331.xsd	Edgar Link	pending
opk-20150331_cal.xml	Edgar Link	unprocessable
opk-20150331_def.xml	Edgar Link	unprocessable
opk-20150331_lab.xml	Edgar Link	unprocessable
opk-20150331_pre.xml	Edgar Link	unprocessable
opk-3312015x10q.htm	Edgar Link	pending
opk-3312015xex311.htm	Edgar Link	pending
opk-3312015xex312.htm	Edgar Link	pending
opk-3312015xex321.htm	Edgar Link	pending
opk-3312015xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2015 Q1 Form 10-Q Financial Statement

#000094480915000008 Filed on May 11, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2015 Q1 Form 10-Q Financial Statement

#000094480915000008 Filed on May 11, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk